Realising individual's mental potential

NeuroBono was founded to provide a service to families with neurological disorders, to foster sustainable and lasting improvement in brain function leading to a brighter future for all. NeuroBono, based in Sallins, Co. Kildare will open its doors in May 2025 in Sallins, and at Queens Tennis Club, London, United Kingdom in July 2025. The founders of NeuroBono have many years of experience addressing special needs. Our clinics will initially focus on supporting families with members who face Autism and ADHD.

Our mission is to enhance the wellbeing of children, adolescents, and adults with Autism Spectrum Disorder (ASD) and Attention Deficit Hyperactivity Disorder (ADHD) through evidence-based EEG (Electroencephalograph) Neurofeedback (NFB) and other solutions. 



Our Target Clients


  • Children, adolescents, and adults diagnosed with Autism, ASD & ADHD.


  • Children, adolescents, and adults symptomatic of Autism, ASD, ADHA and awaiting diagnosis


Our Core Values


We value compassion, scientific rigor, and personalised care. Treatment will be available to all including the most vulnerable and marginalised. In all that we do, we believe the family is central to our approach.






Our Approach & Methodology


Inhouse, our emphasis is EEG Neurofeedback, using the technology of Bee Medic, Zurich, which is the world leader in this field. Bee Medic has provided this technology to over 600 hospitals and to clinics all over the world.

Our clinic has and will continue to assemble a team of licensed Neurofeedback practitioners to ensure high-quality care. In association with BEE Medic and their team of engineers, clinicians, and researchers, we work together in the development of Neurofeedback solutions for clients.

Neurofeedback is a groundbreaking technique that challenges the brain to better function through retraining of the brain waves or EEG. This powerful brain- based technique has been successfully helping clients around the world for over 50 years, with dramatic results for many symptoms. It is Non-invasive, extremely low risk, (meta-analysis published in 2023 reported mild, easily reversible side effects in 5% of 680 subjects (Rahmani, E., 2023)) Medication- free, Produces enduring results, (van Doren, J., 2019).


We utilise:


  • Evidence-based protocols.
  • Personalised training.
  • Ongoing monitoring.
  • Results tracking system.


We strive to increase:


  • Attention.
  • Emotional regulation.
  • Overall well-being.


Long-Term Impact


Our mission is to empower individuals to self-regulate their brain function, leading to sustained improvements in attention, behaviour, and emotional resilience. We will contribute to the advancement of Neurofeedback research and its practice in Ireland and the well-being of patients and their families.